Jennifer F. Tseng

Boston University — United States

Medicine · Health Sciences

42h-index6.6kcitations247works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(30), Gastric Cancer Management and Outcomes(26), Gallbladder and Bile Duct Disorders(23), Cholangiocarcinoma and Gallbladder Cancer Studies(22), Breast Cancer Treatment Studies(20)

Publications245 total

ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
Annals of Surgical Oncology·2025
ASO Visual Abstract: The Real Safety Net Hospitals: High-Medicaid Hospitals Confer Worse Survival for Patients Undergoing Pancreas and Biliary Cancer Surgery
Annals of Surgical Oncology·2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
Annals of Surgical Oncology·2025· 2 cited
Factors Associated With Surgical Management in Gallbladder Cancer—A Surveillance, Epidemiology, and End Results Medicare–Based Study
Journal of Surgical Research·2024· 2 cited
Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Nature Medicine·2024· 8 citedOpen Access
Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Nature Medicine·2024· 31 citedOpen Access
ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial
Annals of Surgical Oncology·2024
ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy—Results from the I-SPY2 Clinical Trial
Annals of Surgical Oncology·2024
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial
Annals of Surgical Oncology·2024· 2 citedOpen Access
Rates of pathologic complete response (pCR) after datopotamab deruxtecan (Dato) plus durvalumab (Durva) in the neoadjuvant setting: Results from the I-SPY2.2 trial.
Journal of Clinical Oncology·2024· 12 cited
Formation and evaluation of the ASCO medical education community of practice (Med Ed CoP).
Journal of Clinical Oncology·2024
Optimising healthcare for Deaf and hard of hearing patients
Prescriber·2024Open Access
Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative
Journal of Surgical Oncology·2024· 5 cited
Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
International Journal of Radiation Oncology*Biology*Physics·2024· 3 cited
Rare Prekallikrein Deficiency Identified During Workup of Isolated Prolonged Activated Partial Thromboplastin Time
Ochsner Journal·2024· 1 citedOpen Access
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Cancer Cell·2023· 3 citedOpen Access
Not Too Little, Not Too Much: Optimizing More Versus Less Locoregional Treatment for Older Patients With Breast Cancer
American Society of Clinical Oncology Educational Book·2023· 4 cited
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer
Breast Cancer Research and Treatment·2023· 16 citedOpen Access
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer
2023· 1 citedOpen Access
Advancing the Clinician Educator Career Pathway in Oncology
JCO Oncology Practice·2022· 1 cited
page 1 of 13Next →

Frequent Co-authors

Shimul A. Shah(19), Sing Chau Ng(16), Nicholas G. Csikesz(8), Jessica P. Simons(7), Youfu Li(7), Joshua S. Hill(5), Barry W. Feig(5), Robert N. Taylor(4), Theodore P. McDade(4), Anand Singla(4), Jillian K. Smith(4), Heena P. Santry(4), Zheng Zhou(3), Giles F. Whalen(3), Waddah B. Al‐Refaie(3), Melissa M. Murphy(3), Elan R. Witkowski(3), Peter W. T. Pisters(3), Omidreza Tabatabaie(3), Gyulnara G. Kasumova(3)